The FDA granted Empirical Spine’s LimiFlex dynamic saggittal tether premarket approval.
LimiFlex is a motion-preserving system for lumbar spinal stenosis associated with Grade I degenerative spondylolisthesis after decompression, according to a Feb. 18 news release. The system was developed from foundational research at Stanford (Calif.) University.
The system stabilizes the spine following decompression without rigid fixation. In an FDA trial Limiflex showed non-inferior two-year clinical outcomes compared with instrumented spinal fusion. Procedures were also shorter than fusions and supported outpatient care.
A limited launch of LimiFlex is expected to begin at select medical centers that participated in the FDA’s IDE trial.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
